Earnings Analyzer
Stock earnings page

AllianceBernstein Holding L.P. (AB)

Track the next or latest earnings date for AllianceBernstein Holding L.P., review consensus estimates, and see cached AI analysis for recent quarterly results.

Recent earnings news

Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
finance.yahoo.com · 1 day ago

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making. Here at Zacks, we prioritize apprais…

Why is SAAB stock surging today? By Investing.com
investing.com · 12 hours ago

Investing.com -- SAAB AB ser. B stock surged 5.1% today after Morgan Stanley issued a double-upgrade on the Swedish defense group, shifting its rating from Underweight to Overweight and raising its 12-month price target to SEK 700 from SEK 540. The bank’s bullish repositioning reflected a view that …

Investor AB B highlights long-term portfolio role as Swedish investment house
ad-hoc-news.de · 10 hours ago

The B shares traded on the Stockholm exchange provide a liquid way for market participants to participate in this strategy. The company typically holds large, long-term positions rather than engaging in short-term trading. These holdings span sectors such as industrial manufacturing, financial servi…

ABT Stock | Abbott Laboratories Price, Quote, News & Analysis - TipRanks.com
www.tipranks.com · 2 weeks ago

Abbott Laboratories lowest stock price was $81.97 and its highest was $139.06 in the past 12 months. ... Abbott Laboratories’s market cap is $160.56B. When is Abbott Laboratories’s upcoming earnings report date?

Abbott Laboratories Q2 Earnings Preview: A Contrarian Buy Opportunity Worth Considering | Seeking Alpha
seekingalpha.com · 4 days ago

Abbott Laboratories (ABT) is due to announce its Q2 2026 earnings around 16th July - the Life Sciences giant has endured a difficult 6 months, its share price down >20%, and in fact 18% on a · If you are interested in keeping up to date with stocks making moves within the biotech, pharma, ...

Latest earnings date

Feb 05, 2026

Time not specified

Fiscal quarter: 2025-12-31

EPS estimate: $0.95

Revenue estimate: N/A

Market cap: $3.29B

Analysis snapshot

No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.

Recent earnings history

Browse the calendar week
Date Quarter Report window EPS est. Revenue est.
Feb 05, 2026 2025-12-31 Time not specified $0.95 N/A